ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 70 filers reported holding ACELRX PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 2.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $655,000 | +45.2% | 385,140 | +6.0% | 0.00% | – |
| Q4 2020 | $451,000 | -12.3% | 363,425 | +0.5% | 0.00% | – |
| Q3 2020 | $514,000 | +38.2% | 361,665 | +17.6% | 0.00% | – |
| Q2 2020 | $372,000 | -25.2% | 307,442 | -27.0% | 0.00% | – |
| Q1 2020 | $497,000 | -44.1% | 421,071 | -0.0% | 0.00% | – |
| Q4 2019 | $889,000 | +101.1% | 421,200 | +109.4% | 0.00% | – |
| Q3 2019 | $442,000 | -13.2% | 201,189 | 0.0% | 0.00% | – |
| Q2 2019 | $509,000 | – | 201,189 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 5,408,728 | $17,037,000 | 0.97% |
| WealthTrust Axiom LLC | 140,000 | $441,000 | 0.16% |
| Palo Alto Investors LP | 1,032,715 | $3,253,000 | 0.15% |
| SHEPHERD KAPLAN KROCHUK, LLC | 49,761 | $157,000 | 0.08% |
| Joel Isaacson & Co., LLC | 80,660 | $254,000 | 0.05% |
| Malaga Cove Capital, LLC | 10,250 | $31,000 | 0.02% |
| Cornerstone Capital, Inc. | 30,000 | $95,000 | 0.02% |
| Granahan Investment Management | 31,298 | $99,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 244,150 | $769,000 | 0.01% |
| Advisor Group, Inc. | 117,657 | $371,000 | 0.01% |